Skip to main content

Advertisement

SpringerLink
Log in

Second Trimester Medication Abortion Regimens and the Mifepristone-Misoprostol Dosing Interval

  • REVIEW
  • Published:
Current Obstetrics and Gynecology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The purpose of this article is to review current methods of induction termination of pregnancy in the second trimester. The specific area of focus is recent publication regarding timing of mifepristone and misoprostol dosing. Current international guidelines recommend initial treatment with mifepristone followed by misoprostol after 24 to 48 h.

Recent Findings

Retrospective studies indicate that a shorter interval between mifepristone and misoprostol of less than 12 h or even concomitant administration may result in a shorter total abortion time without increasing risk of incomplete abortion or complications.

Summary

Given the potential benefit of increased efficacy, with successful expulsion of the pregnancy, and reduced time to delivery with shorter mifepristone-misoprostol intervals or concurrent administration practitioners should offer all second trimester medication abortion treatment with mifepristone. Further studies are needed to evaluate the implementation of concurrent or varied dosing intervals and the magnitude of benefit vs risks, with attention to the patient experience, resources, and costs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Cohen MA, Kapp N, Edelman A. Abortion care beyond 13 weeks’ gestation: a global perspective. Clin Obstet Gynecol. 2021;64(3):460–74.

    Article  PubMed  Google Scholar 

  2. Dodd JM, Crowther CA. Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death. Cochrane Database of Syst Rev 2010;4:CD004901. https://doi.org/10.1002/14651858.CD004901.pub2. Accessed 07 December 2022.

  3. Abediasl Z, Sheikh M, Pooransari P, Farahani Z, Kalani F. Vaginal misoprostol versus intravenous oxytocin for the management of second-trimester pregnancies with intrauterine fetal death: a randomized clinical trial. J Obstet Gynaecol Res. 2016;42(3):246–51.

    Article  CAS  PubMed  Google Scholar 

  4. The Care of Women Requesting Induced Abortion (Evidence-based Clinical Guideline No. 7). Royal College of Obstetricians & Gynaecologists (RCOG). November 2011, reaffirmed 2018.

  5. Abortion care guideline. Geneva: World Health Organization (WHO); 2022. License: CC BY-NC-SA 3.0 IGO.

  6. Anselem O, Jouannic JM, Winer N, Bouchghoul H, Vivanti AJ, Quibel T, Massardier J, Rousseau J, Ancel PY, Goffinet F, Tsatsaris V. Cervical dilators used concurrently with misoprostol to shorten labor in second-trimester termination of pregnancy: a randomized controlled trial. Obstet Gynecol. 2022 Sep 1;140(3):453–460. https://doi.org/10.1097/AOG.0000000000004887. Epub 2022 Aug 3. Erratum in: Obstet Gynecol. 2022;140(5):902. PMID:35,926,202.

  7. Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality. Obstet Gynecol. 2003;101(6):1294–9.

    CAS  PubMed  Google Scholar 

  8. Green J, Borgatta L, Sia M, Kapp N, Saia K, Carr-Ellis S, Vragovic O. Interventions rates for placental removal following induction abortion with misoprostol. Contraception. 2007;76(4):310–3.

    Article  CAS  PubMed  Google Scholar 

  9. Berghella V, Airoldi J, O’Neill AM, Einhorn K, Hoffman M. Misoprostol for second trimester pregnancy termination in women with prior cesarean: a systematic review. BJOG. 2009;116:1151–7.

    Article  CAS  PubMed  Google Scholar 

  10. Borgatta L, Kapp N. Society of Family Planning. Clinical guidelines. Labor induction abortion in the second trimester Contraception. 2011;84(1):4–18. https://doi.org/10.1016/j.contraception.2011.02.005. Epub 2011 Mar 30. PMID:21664506.

    Article  PubMed  Google Scholar 

  11. Perritt JB, Burke A, Edelman AB. Interruption of nonviable pregnancies of 24–28 weeks’ gestation using medical methods: release date June 2013 SFP guideline #20,133. Contraception. 2013;88(3):341–9.

    Article  PubMed  Google Scholar 

  12. Vlad S, Boucoiran I, St-Pierre ÉR, Ferreira E. Mifepristone-misoprostol use for second- and third-trimester medical termination of pregnancy in a Canadian tertiary care centre. J Obstet Gynaecol Can. 2022;44(6):683–689. https://doi.org/10.1016/j.jogc.2021.12.010. Epub 2022 Feb 1. PMID:35,114,381.

  13. Wildschut H, Both MI, Medema S, Thomee E, Wildhagen MF, Kapp N. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev. 2011;2011(1):CD005216. https://doi.org/10.1002/14651858.CD005216.pub2. PMID:21,249,669; PMCID:PMC8557267.

  14. Prodan N, Breisch J, Hoopmann M, Abele H, Wagner P, Kagan KO. Dosing interval between mifepristone and misoprostol in second and third trimester termination. Arch Gynecol Obstet. 2019;299(3):675–679. https://doi.org/10.1007/s00404-018-5017-9. Epub 2018 Dec 21. PMID:30,578,439

  15. •• Henkel A, Lerma K, Blumenthal PD, Shaw KA. Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study. Contraception. 2020 Nov;102(5):327–331. https://doi.org/10.1016/j.contraception.2020.06.009. Epub 2020 Jun 25. PMID:32,592,800. A retrospective review of 89 persons with gestations 15–27 weeks who received misoprostol and mifepristone at different dosing intervals (less than 12 h, 12–24 h, and greater than 24 h) and a subsequent analysis of total induction time as well as total abortion time.

  16. •• Shay RL, Benson LS, Lokken EM, Micks EA. Same-day mifepristone prior to second-trimester induction termination with misoprostol: a retrospective cohort study. Contraception. 2022;107:29–35. https://doi.org/10.1016/j.contraception.2021.09.006. Epub 2021 Sep 13. PMID:34,529,952. A retrospective review of 298 persons with gestations 14–28 weeks who received misoprostol and mifepristone at varying intervals and an analysis of time to fetal expulsion.

  17. Allanson ER, Copson S, Spilsbury K, et al. Pretreatment with mifepristone compared with misoprostol alone for delivery after fetal death between 14 and 28 weeks of gestation: a randomized controlled trial. Obstet Gynecol. 2021;137(5):801–9. https://doi.org/10.1097/AOG.0000000000004344.

    Article  CAS  PubMed  Google Scholar 

  18. Dadhwal V, Garimella S, Khoiwal K, Sharma KA, Perumal V, Deka D. Mifepristone followed by misoprostol or ethacridine lactate and oxytocin for second trimester abortion: a randomized trial. Eurasian J Med. 2019;51(3):262–266. https://doi.org/10.5152/eurasianjmed.2019.18341. Epub 2019 Aug 19. PMID:31,692,613; PMCID:PMC6812907.

  19. Whitehouse KC, Stifani BM, Duffy JMN, Kim CR, Creinin MD, DePiñeres T, Winikoff B, Gemzell-Danielsson K, Blum J, Sherman RB, Lavelanet AF, Brahmi D, Grossman D, Tamang Gebreselassie H, Ponce de Leon RG, Ganatra B. Standardizing abortion research outcomes (STAR): results from an international consensus development study. Contraception. 2021 Nov;104(5):484–491. https://doi.org/10.1016/j.contraception.2021.07.004. Epub 2021 Jul 14. PMID:34,273,335; PMCID:PMC8609158.

  20. National Guideline Alliance (UK). Medical abortion after 24 weeks’ gestation: abortion care: evidence review L. London: National Institute for Health and Care Excellence (NICE); 2019 Sep. PMID:32,813,471.

  21. Valero I, Garcia-Jimenez R, Weber-Fernandez AM, et al. Combination of mifepristone and misoprostol vs misoprostol monotherapy for treatment of second-trimester pregnancy loss. Eur J Contracept Reprod Health Care. 2022;27(4):341–4. https://doi.org/10.1080/13625187.2022.2054982.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Montefiore Hospital & Albert Einstein College of Medicine, 1695 Eastchester Road Bronx, 10461, Boston, NY, USA

    Emma M. Smith & Jessica Atrio

  2. Division of Family Planning, Massachusetts General Hospital, Boston, MA, USA

    Katherine Pocius

Authors
  1. Emma M. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katherine Pocius
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jessica Atrio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emma M. Smith.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, E.M., Pocius, K. & Atrio, J. Second Trimester Medication Abortion Regimens and the Mifepristone-Misoprostol Dosing Interval. Curr Obstet Gynecol Rep 12, 83–87 (2023). https://doi.org/10.1007/s13669-023-00358-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13669-023-00358-7

Keywords

Search

Navigation